Product Images Zonisamide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Zonisamide NDC 59651-379 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 Proportion of Patients Achieving Differing Levels - zonisamide fig1
PACKAGE LABEL PRINCIPAL DISPLAY PANEL - 25 mg (30 Tablet Bottle) - zonisamide fig2
PACKAGE LABEL PRINCIPAL DISPLAY PANEL - 50 mg (30 Tablet Bottle) - zonisamide fig3
This is a description of Zonisamide Capsules containing 50 mg of the active ingredient, sold by Aurobindo Pharma USA, Inc. The drug is only available by prescription and the full prescribing information is included in the package insert. The medication guide is provided separately to each patient. The capsules should be stored at room temperature in a dry place and protected from light. The dotted lines indicate an over printing zone coding area.*
PACKAGE LABEL PRINCIPAL DISPLAY PANEL - 100 mg (30 Tablet Bottle) - zonisamide fig4
Zonisamide Capsules, USP is a medication distributed by Aurobindo Pharma USA, Inc. The usual dosage is to be referred to the package insert for complete prescribing information. The capsules contain 100 mg of the active ingredient Zonisamide USP. The medication guide should be dispensed separately to each patient. The capsules should be stored in a dry place and protected from light at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F).*
Chemical Structure - zonisamide str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.